MetLife (MET)
(Delayed Data from NYSE)
$57.94 USD
+0.89 (1.56%)
Updated Mar 31, 2023 04:00 PM ET
After-Market: $57.93 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
MetLife (MET) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$77.09 | $90.00 | $60.00 | 35.13% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for MetLife comes to $77.09. The forecasts range from a low of $60.00 to a high of $90.00. The average price target represents an increase of 35.13% from the last closing price of $57.05.
Analyst Price Targets (11)
Broker Rating
MetLife currently has an average brokerage recommendation (ABR) of 1.71 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.71 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, seven are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 58.33% and 8.33% of all recommendations. A month ago, Strong Buy made up 58.33%, while Buy represented 8.33%.
Broker Rating Breakdown

Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 7 | 7 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 4 | 3 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.71 | 1.71 | 1.71 | 1.59 | 1.45 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | From | To |
---|---|---|---|---|
2/14/2023 | Dowling & Partners | Geoffrey M Dunn | Not Available | Hold |
12/9/2022 | Jefferies & Company | Suneet Kamath | Hold | Hold |
9/22/2022 | Raymond James | Wilma Burdis | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.71 |
ABR (Last week) | 1.71 |
# of Recs in ABR | 12 |
Average Target Price | $77.09 |
LT Growth Rate | 13.30% |
Industry | Insurance - Multi line |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | 1.74 |